A new study published by Associate Professor Warren Rose reactivates two beta-lactam antibiotics against strains of MRSA in a lab simulation.

A new study published by Associate Professor Warren Rose reactivates two beta-lactam antibiotics against strains of MRSA in a lab simulation.
With a new R01 grant from the National Institutes of Health, Associate Professor Warren Rose is testing a MRSA subset that might not be as resistant to beta-lactams as previously thought.
Professor Tim Bugni and his colleagues receive $30 million grant from the NIH to take aim at the growing threat of multi-drug-resistant pathogens for which few — or no — treatment options exist.